Biocrates

Innsbruck, Austria Founded: 2002 • Age: 24 yrs Acquired By Bruker
Targeted metabolic phenotyping kits are developed for research and diagnostics.

About Biocrates

Biocrates is a Healthcare company based in Innsbruck (Austria) founded in 2002, and was acquired by Bruker in June 2025. Targeted metabolic phenotyping kits are developed for research and diagnostics. Biocrates has raised $7.87 million across 9 funding rounds from investors including BASF, Bruker and European Union. Biocrates has completed 1 acquisition, including Metanomics Health. Its website biocrates.com draws about 28 thousand monthly visits. Biocrates offers products and services including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ. Its focus areas include Life Sciences, Metabolic Diseases, In Vitro Diagnostic Tests and Endocrine Disorders. Its legal entity is biocrates life sciences ag.

Company details

Biocrates was founded in 2002 in Innsbruck, Austria, within the life sciences sector. Kits for targeted metabolic phenotyping are offered in two lines: research tools that quantify 188 metabolites across classes like bile salts and steroids, and diagnostic tests for analyzing 16 steroid hormones. Proprietary software is utilized to manage workflows, standardize data processing, and support project harmonization in metabolite analysis.

  • Headquarters Innsbruck, Austria
  • Stage Acquired
  • Sectors
    Healthcare
  • Website biocrates.com
  • Social LinkedIn X YouTube
  • Acquired by Bruker (Jun 2025)
  • Legal Name Biocrates Life Sciences Ag
Key Metrics

Products & Services of Biocrates

Biocrates offers a comprehensive portfolio of products and services, including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ.

MxP Quant 500 XL
Targeted Profiling Kit

Kit for comprehensive metabolic profiling of lipids and small molecules.

MxP Quant 500
Targeted Profiling Kit

Kit to study disease mechanisms and microbiome interactions.

AbsoluteIDQ p400 HR
Metabolomics Software

High-resolution tool for targeted metabolomics data analysis.

WebIDQ
Data Analysis Software

Software for sample registration and metabolite quantification.

Apps and channels of Biocrates

its YouTube channel biocrates life sciences has 1.25K subscribers and 30 videos.

biocrates life sciences
YouTube 1.25K subscribers 30 videos Science & Technology
Open channel

Videos from Biocrates

The most watched videos on Biocrates's YouTube channel, biocrates life sciences (1.25K subscribers). Click a video to play it here.

Scalable metabolomics in population health
338 views
biocrates - The future of research and health
316 views
MxP Quant 1000 assay making the difference
196 views
Leveraging the metabolome and the microbiome from epidemiological studies in cardiometabolic disease
195 views

More on biocrates life sciences.

Funding Insights of Biocrates

Biocrates has successfully raised a total of $7.87M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.87M
  • Total Rounds 9
  • First Round $6.27M

    (Jun 2006)

  • Investors Count 5

All 9 funding rounds of Biocrates with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2019Series B–MIG Fonds, Global Asset Fund
–
Feb 2018$197,379Grant––
–
Jan 2018Series B–BASF, MIG Fonds
–
Jan 2018$190,337Grant––
Jan 2017$269,394Grant––
–
Mar 2010$1.6MSeries B–Arax Capital Partners
–
Jan 2010Grant––
–
Jun 2008Series B–MIG Fonds
–
Jun 2006$6.27MSeries A–MIG Fonds
–
Valuation history

6 investors in total: 6 institutional.

Investors in Biocrates

Biocrates has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include BASF, Bruker and European Union.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in technology companies are managed by MIG Fonds.
mig-fonds.deGermany
global-asset-fund.de
Investments are focused on Austrian tech and life sciences startups.
arax.atVienna, Austria
Chemicals and related products are produced and marketed globally.
1865basf.comFlorham Park, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Diversified research instrument systems are manufactured and supplied.
1960bruker.comUnited States
Premium access

Investor details for Biocrates

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biocrates

6 people are tracked at Biocrates (2 in leadership, 4 in team).

NameRoleGroup
Guido D.
Laboratory HeadLeadership
Alice Limonciel
Chief Scientific OfficerLeadership
Gordian Adam
Senior Scientist | Team Lead Insights & InnovationTeam
Ulf Sommer
Principal Scientist Product DevelopmentTeam
Gregor Ömer
Scientist - Team Lead ProductionTeam
Enrique Ozcariz García
Junior Scientist DI | Biostatistics and Data InterpretationTeam
Premium access

Complete people profiles for Biocrates

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biocrates

Biocrates has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Metanomics Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Metabolomics products and services are offered for health applications.
metanomics-health.comBerlin, Germany2003Jan 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Biocrates

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Biocrates

5 dated milestones of Biocrates across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biocrates is founded.
  2. Funding First funding round of $6.3M.
  3. Acquisition Acquires Metanomics Health.
  4. Funding Latest funding round, Series B,.
  5. Exit Acquired by Bruker.

Web traffic of Biocrates

The website of Biocrates (biocrates.com) receives about 28.4K visits a month.

  • Monthly visits
    28.4K

    ▲ 53.4% vs previous month

Similar websites

Websites whose visitors overlap most with Biocrates. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
eclub.biomart.cn
eclub.biomart.cn
100%
–
metlin.scripps.edu
metlin.scripps.edu
98%
–
metabolomicsworkbench.org
metabolomicsworkbench.org
98%
#671,682–
zbsa.uni-freiburg.de
zbsa.uni-freiburg.de
97%
–
dbkgroup.org
dbkgroup.org
96%
#7,430,362–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for Biocrates

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biocrates

Premium access

Complete news archive for Biocrates

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biocrates

Biocrates was founded in 2002 and raised its 1st funding round 4 years after it was founded.

Biocrates is headquartered in Innsbruck, Austria. It is registered at Innsbruck, Tyrol, Austria.

Biocrates is a funded company, having raised a total of $7.87M across 9 funding rounds to date. The company's 1st funding round was a Series A of $6.27M, raised on Jun 2006.

Biocrates was founded in 2002 in Innsbruck, Austria, within the life sciences sector. Kits for targeted metabolic phenotyping are offered in two lines: research tools that quantify 188 metabolites across classes like bile salts and steroids, and diagnostic tests for analyzing 16 steroid hormones. Proprietary software is utilized to manage workflows, standardize data processing, and support project harmonization in metabolite analysis.

Biocrates offers MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ.

Biocrates has made 1 acquisition, including Metanomics Health.

Biocrates has 6 investors. Key investors include BASF, Bruker, European Union, MIG Fonds, and Global Asset Fund.

Biocrates operates through Biocrates Life Sciences Ag.

Yes. Biocrates was acquired by Bruker in June 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available